Skip to main content
. 2022 Oct 23;14(21):5199. doi: 10.3390/cancers14215199

Table 1.

Criteria for risk stratification of recurrence and death of patients diagnosed with breast cancer (based on Goldhirsch et al. [4]).

Low risk Negative lymph nodes and all the following criteria:
pT under 2 cm;
Histological grade 1;
ER or PR positive;
HER-2 negative;
Molecular subtype luminal A; and
Age equal to or above 35 years old.
Intermediate risk Negative lymph nodes and at least one of the following criteria:
pT higher than 2 cm; or
Histological grade 2–3; or
ER or PR negative; or
Molecular subtype luminal B (HER-2 negative); or
Age under 35 years old; or yet
1 to 3 affected lymph nodes if ER and PR positive.
High risk 4 or more positive lymph nodes; or
Lymph nodes negative with ER. PR and HER-2 negative. pT higher than 2 cm; or
Lymph node negative. pT higher than 1 cm and HER-2 positive.

pT: tumor size; ER: estrogen receptor; PR: progesterone receptor; HER-2: human epidermal growth factor receptor 2.